# Soleno Therapeutics, Inc.

Type: Company

Source: Healthcare Intelligence Brief — https://gethealthbrief.com/entity/soleno-therapeutics-inc
Canonical HTML page: https://gethealthbrief.com/entity/soleno-therapeutics-inc

## Recent coverage (1 stories)

### Soleno and Ultragenyx Face Securities Fraud Litigation Over Disclosure Risks
2026-03-12 10:05:39 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

The Schall Law Firm has initiated securities fraud class action lawsuits against rare disease biotechs Soleno Therapeutics and Ultragenyx Pharmaceutical. These legal challenges highlight the heightened scrutiny on clinical data transparency and regulatory communications in the high-stakes orphan drug sector.
Full story: https://gethealthbrief.com/story/soleno-ultragenyx-securities-fraud-lawsuits-2026

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://gethealthbrief.com/guides/methodology for the full editorial methodology.